You are here

Articles of Interest


Goldberg, Paul and Matthew Ong. "Doug Lowy on the moonshot, NCI’s invigorated agenda." The Cancer Letter, January 6, 2017.

As administrations change, cancer research stands in an unusually strong position, NCI Acting Director Douglas Lowy said in an interview with The Cancer Letter.


Donohue, Thomas J. "Business Community All In on Cancer Moon Shot." Above the Fold, August 15, 2016.

In 1969, America put a man on the Moon, a breathtaking achievement that many said couldn't be done.

Coburn, Tom and Daniel P. Petrylak. "Want to really speed up cancer research? Start sharing more data." STAT News, May 17, 2016.

   "Enclaves" for cancer data that give access to participating researchers, cancer centers, pharma companies, and others can speed cancer therapy development.


Project Data Sphere, which launched on April 8, is a “giant digital laboratory, an enormous library containing data about tens of thousands of patients and hundreds of clinical trials, all of which will be in the public domain,” said Martin J. Murphy, Jr, DMedSc, PhD, FASCO, Chief Executive Officer of the CEO Roundtable on Cancer.

The answer, of course, is learning how to share. In medicine, the question is when, and how, to share data. The hope (and hype) of Big Data is that massive datasets can help researchers and companies slice and dice cancer into smaller, more manageable patient populations where companies can rapidly develop, test, and launch new cancer targeted drugs and diagnostics. The goal, of course, is to generate much better patient outcomes, at much lower cost, than the status quo.

Big Pharma spends billions of dollars each year researching, developing and testing new treatments for cancer. In the meantime, it’s also collecting millions of data points that figuratively sit on a shelf and collect dust once a clinical trial is complete. A consortium of Big Pharma companies and research organizations are attempting to give that raw data a second life by making it available to researchers on the new Project Data Sphere platform.

The Life Sciences Consortium of the CEO Roundtable on Cancer today announced the launch of the Project Data Sphere initiative, a platform designed to facilitate the sharing, integration and analysis of data from phase 3, comparator arm cancer trials.

Project Data Sphere, LLC (PDS) is an independent, not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium (LSC), a group formed by President Bush in 2001 to look at the ways in which different organisations can come together to improve outcomes in cancer research that no individual group could do by itself. The data-sharing platform is one of the projects developed by the group.

Munro, Dan. "Big Pharma Opens New Chapter on Big Data Collaboration." Forbes, April 08, 2014.

In the course of one short week, no less than 3 different models have emerged for sharing big data in the pharmaceutical industry. The highest profile of these ‒ called Project Data Sphere (PDS here) ‒ was announced earlier today with the official opening of an online resource to share clinical trial data for use in cancer research.

The initiative, announced today, will mark the launch of a new data sharing platform, with the goal of advancing research to improve the lives of cancer patients and their families around the world. The CEO Roundtable on Cancer was established in 2001 with the mandate to bring bold and imaginative solutions to cancer care.


Weldon, William C. "CEO Roundtable on Cancer Member Newsletter." Winter 2010.

A message from CEO Roundtable on Cancer chairman Bill Weldon.